Background: Bullous pemphigoid is an autoimmune disease that typically presents with tense bullae and severe pruritus. However, bullae can be lacking, a subtype termed nonbullous pemphigoid.
B
ullous pemphigoid (BP) is the most common autoimmune bullous disease affecting the skin and mucosal membranes, with autoantibodies directed against the 180-kDa BP antigen (BP180) and the 230-kDa BP antigen (BP230) located in the basement membrane zone. 1 The disease commonly affects older patients and is associated with an increased risk for mortality, as well as a significant decline in quality of life and psychologic well-being. [2] [3] [4] [5] [6] The clinical phenotype of pemphigoid is polymorphic. The typical presentation consists of tense blisters that arise on erythematous, urticarial indirect immunofluorescence plaques and is accompanied by severe pruritus. 1, 3 Before blister formation, pruritus can occur as a prodrome, with or without primary skin manifestations. 7 In contrast to the typical bullous presentation, various atypical variants of pemphigoid have been reported with terms such as papular pemphigoid, pemphigoid nodularis, pemphigoid vegetans, erythrodermic pemphigoid, pruritic nonbullous pemphigoid, and erythema multiforme-like pemphigoid. [8] [9] [10] [11] The nonbullous variant of pemphigoid presents with pruritus and various nonbullous findings on the skin, such as erythematous patches, urticarial plaques, papules, nodules, excoriations, eczema, and erythroderma. Moreover, this variant can even present without primary skin lesions, in which case it is called pruritus on primary, nondiseased, noninflamed skin according to the International Clinical Classification of Itch. 11, 12 Cohort studies show that at least 20% of all pemphigoid patients do not have blisters at the time of diagnosis. 3, 13 Thus, nonbullous pemphigoid is not that uncommon or atypical as might be assumed. 14 Bullous and nonbullous pemphigoid are immunologically indistinguishable. The diagnosis is usually based on the combination of clinical presentation, histopathologic findings, direct immunofluorescence (DIF) microscopy, and immunoserology. 13 One of the main obstacles currently is the lack of consensus on the minimal diagnostic criteria of pemphigoid. 8, [14] [15] [16] [17] The absence of blistering in nonbullous pemphigoid can make the recognition of this disease difficult for clinicians and might result in a delay of diagnosis. 18, 19 The aim of our study was to characterize and define nonbullous pemphigoid by systematic review, which has not been performed previously. Our study lists reported clinical presentations, histopathologic findings, laboratory findings, and prognosis regarding patients with nonbullous pemphigoid.
MATERIALS AND METHODS

Search strategy
The literature search for this review was conducted in the EMBASE and MEDLINE databases on November 4, 2016. Various terms and synonyms for ''nonbullous pemphigoid'' (Supplementary Appendix; available at http://www.jaad.org) were used. There were no limitations on article type. After the selection procedure, the references of all included articles were checked for missing articles.
Selection of articles
Language was limited to Dutch, German, or English. Independent screening of the titles and abstracts was carried out by Drs Lamberts and Meijer. Discrepancies between the researchers were resolved through discussion. All articles reporting on 1 or multiple cases of nonbullous pemphigoid were included. Nonbullous pemphigoid was defined as all symptomatic cases with a nonbullous phenotype that lacked a previous history of bullae and fulfilled the following diagnostic criteria of pemphigoid: a positive DIF with linear IgG and/or C3c along the basement membrane zone and/or positive indirect immunofluorescence (IIF), in combination with compatible clinical presentation, histopathologic findings, or other immunoserologic tests. If the full text was not available online, the text was ordered at the national library. Poster abstracts were only included if sufficient individual patient data was presented.
Data collection
The following variables were gathered: age at diagnosis, sex, duration of symptoms before diagnosis, clinical presentation, results of diagnostic tests, histopathologic findings, total follow-up time, and blisters development during follow-up. Statistical analyses were done in IBM SPSS statistics 23.
RESULTS
Systematic search results
A total of 39 articles presenting a total of 132 cases of nonbullous pemphigoid were identified (Supplemental Table I ; available at http://www. jaad.org). 10, 11, Fig 1 displays the selection procedure. The first case of nonbullous pemphigoid was reported in 1983 by Barker et al. 20 The largest case series was from Lamb et al, 21 who described the clinical presentation of 53 patients diagnosed with ''prodromal bullous pemphigoid.'' This large case series did not present individual patient characteristics concerning age, sex, duration of symptoms, histopathologic findings, and total duration of follow-up. However, we were able to include the reported clinical presentation and the number of cases that developed blisters during follow-up. Table I shows the demographics of the reported patients with nonbullous pemphigoid. The mean age at presentation was 74.9 years. The reported efflorescences and configurations of skin lesions seen at dermatologic examination are displayed in Table II. Table III presents the location of skin lesions reported in 64 of the 132 cases.
Clinical presentation
Histopathology
The histopathologic findings were described in 53 individual cases. A perivascular infiltrate was seen most frequently (n = 32; 60.4%), which is a nonspecific finding. In addition, nonspecific findings not further specified were reported in 14 cases (26.4%). Eosinophils were present in the biopsies of 25 cases (47.2%) and neutrophils in 7 cases (13.2%). Spongiosis without eosinophils was reported in 10 cases (18.9%), and eosinophilic spongiosis was seen in 4 patients (7.5%). The presence of dermal edema was reported in 8 cases (15.1%). The presence of a microscopic subepidermal split was reported in 8 patients (15.1%). Table IV shows the reported laboratory findings of patients with nonbullous pemphigoid. In all cases, DIF microscopy was performed. In cases with negative DIF results, the diagnosis was based on positive IIF with additional serologic tests that specified the targeted antigen. IIF was the most commonly performed immunoserologic test (55 cases). The substrate used in IIF was not specified in 15 cases. In the other cases monkey esophagus (n = 27) or human skin (n = 13) were used as substrate. The BP230 enzyme-linked immunosorbent assay was the least performed immunoserologic test (n = 19). In addition, in 4 cases, immunoprecipitation was used to identify antigens, resulting in a positive reaction to both BP180 and BP230 in 1 case and a positive reaction to only BP230 in 3 cases. Eosinophilia of the peripheral blood was reported in 13 of 15 cases (86.7%).
Laboratory findings
DISCUSSION
This systematic review summarizes the reported characteristics of nonbullous pemphigoid. The most frequently reported skin efflorescences were erythematous, urticarial plaques (52.3%). Pruritus was reported in 100% of the cases. Overall, the duration between the start of symptoms and the correct diagnosis was very long (mean 22.6 months). Only 13 patients (9.8%) developed bullae during the reported follow-up; thus only 13 cases were actually prodromal to bullous pemphigoid. However, for most of the cases (90.2%) bullae never occurred. The findings of this review show that although the clinical presentation of nonbullous pemphigoid is various, pruritus at an older age might be a clinical clue.
Our study identified several similarities in clinical characteristics of nonbullous and bullous pemphigoid. Both present at older age (mean 74.9 years in nonbullous pemphigoid versus 77.2-82.6 years in bullous pemphigoid). [4] [5] [6] Furthermore, in both variants lesions are most frequently located on the trunk and extremities. 18, 57 Most of the skin efflorescences reported in nonbullous pemphigoid cases can also be found in patients with bullous pemphigoid. 1, 13 On the other hand, mucosal involvement was rarely reported in nonbullous pemphigoid and was reported in 10%-30% of patients with bullous pemphigoid. 3, 13, 57 In 14 cases, the configurations of the skin lesions were reported to be annular, gyrate, figurate, or herpetiform. 21, [23] [24] [25] [26] [27] [28] [29] [30] Two of these patients presented with targetoid lesions. 21, 25 We also found 3 case reports that were possibly drug-induced due to nifedipine, lisinopril, and the combination of allopurinol plus colchicine. 25, 31, 32 Nifedipine and lisinopril were previously associated with bullous pemphigoid; however, it has not been shown that these drugs cause a higher risk to develop bullous pemphigoid. 58, 59 Studies did show that the use of spironolactone and neuroleptics are independent risk factors for the development of bullous pemphigoid. 60, 61 The reported histopathologic findings in nonbullous pemphigoid differ from bullous pemphigoid in several aspects. Histopathologic findings were commonly nonspecific in nonbullous pemphigoid and resembled eczema or prurigo nodularis. Although bullous pemphigoid is usually characterized by the presence of eosinophilic spongiosis ([50%) and a subepidermal split (680%), in the cases with nonbullous pemphigoid, histopathologic findings only described eosinophilic spongiosis in 7.5% and a subepidermal split in 15.1%. 1, 62 These findings emphasize the need to J AM ACAD DERMATOL VOLUME 78, NUMBER 5 always perform DIF microscopy and immunoserology in addition to histopathology in patients in which nonbullous pemphigoid is suspected. In nonbullous pemphigoid, DIF microscopy was the most reported positive diagnostic test (positive in 93.2%) followed by IIF on salt-split skin (90.2%). Both DIF microscopy and IIF on salt-split skin have a high specificity (98% and 100%, respectively). 63 Yet, the reported percentage of positive findings in DIF microscopy in nonbullous pemphigoid might be an overestimation, considering this test is regarded as the reference standard for diagnosis of pemphigoid and commonly the only performed immunopathologic test. 64 Consequently, the diagnosis of pemphigoid might be rejected when DIF microscopy is negative, and immunoserologic analysis might not have been performed.
The mean duration of symptoms of nonbullous pemphigoid until the correct diagnosis of pemphigoid was 22.6 months. These results seem to be consistent with other research that also found long diagnostic delays in pemphigoid cases that lack bullae. Previously, we reported a mean delay in diagnosis of 33.6 months in 15 patients with nonbullous pemphigoid. 11 The studies of Zhang et al and Sun et al reported misdiagnosis with eczema, nodular prurigo, or other dermatologic diseases in all pemphigoid patients that initially presented without bullae, which were 181 and 24 cases respectively. 18, 65 In both studies, the correct diagnosis was made when bullae appeared, which was after a mean duration of 15.9 months and 20.75 months (range 1 month-19 years). Although these studies only identified misdiagnosis in prodromal bullous pemphigoid patients, they also illustrate the importance of more awareness and better knowledge regarding the characteristics of nonbullous pemphigoid. In contrast, Della Torre et al did not find a significant difference in delay of diagnosis between patients with bullous (n = 97) and nonbullous (n = 20) pemphigoid in their cohort. 3 Whether early recognition and immunosuppressive treatment of nonbullous pemphigoid can prevent later blister development is unknown.
A much debated question is whether patients diagnosed with nonbullous pemphigoid are prodromal or have a distinct pemphigoid variant. 10, 21 The finding that most nonbullous pemphigoid patients did not develop blisters during follow-up supports the hypothesis that nonbullous pemphigoid is not a prodromal stage but merely a variant within the clinical spectrum of pemphigoid diseases. We can conclude that prodromal pemphigoid is an incorrect term and that there is a need for consensus regarding the terminology to describe this disease variant. We strongly argue for insertion of the term nonbullous pemphigoid in the EMTREE.
During our literature search we identified a number of other subepidermal autoimmune blistering diseases with nonbullous clinical presentations: nonbullous epidermolysis bullosa acquisita, 66 nonbullous linear IgA dermatosis, 67 and nonbullous pemphigoid gestationis. 68 Furthermore, we came across reports of pemphigoid patients that first presented with bullae and later experienced a nonbullous flare-up of the disease. 45, 49, [69] [70] [71] [72] These cases strengthen the idea that nonbullous pemphigoid should be seen as a disease variant within the spectrum of pemphigoid diseases. Previous publications reported a higher prevalence of BP-specific autoantibodies in older dermatology patients ([75 years) without blisters, healthy blood donors, and elderly individuals with pruritus. [73] [74] [75] How these patients fit the pemphigoid spectrum has not been clarified.
Our systematic review provides insight on reported literature on nonbullous pemphigoid. A limitation of this review is that the results are mainly based on single case reports and small case series. As 77, 78 and eosinophils. 79 More knowledge of the underlying pathophysiology of this subtype of pemphigoid might lead to more awareness and less delay in diagnosis of nonbullous pemphigoid.
In conclusion, our review showed that the reported clinical presentation of nonbullous pemphigoid can be heterogeneous. The reported long duration of symptoms until correct diagnosis (mean 22.6 months) illustrates that nonbullous pemphigoid can be difficult to recognize for clinicians. Pruritus in elderly patients is a common denominator in patients with nonbullous pemphigoid and, in our opinion, the most important clue for recognition. Clinicians should, therefore, perform DIF on a skin biopsy and immunoserologic analysis on a blood sample for elderly patients with unexplained or refractory chronic pruritus and erythematous, urticarial papules and plaques. Further study is needed to evaluate the prevalence of nonbullous pemphigoid. 
